By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Dynamic Business Location.

Smartfactory – Pilot plant Industry 4.0

© Peter Melbinger – Graz University of Technology

State-of-the-art production technologies are made available on an area of about 300 m². This includes additive and laser-assisted manufacturing, collaborative robotics, hybrid technologies and connectivity to modern communications technology as well as Big Data analytics for testing and researching into industrial production applications. Companies can test the research and manufacturing of innovations in the field of Industry 4.0 under laboratory conditions before they are integrated into the regular production chain.

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • ABA's Open Day 2021: Austria - Your ICT and Innovation Hub in the Heart of Europe

    11 March 2021/ 09.00am + 05.00 pm, Online Conference

  • Meet us @ International Machinery Forum 2021 - The Factory of Tomorrow

    11.03 - 12.03 2021, Online Conference

Austria Map

Find the perfect location for your company

Vienna is the driving force for innovations in our company, and one of the growth drivers.

Ottobock Austria

Logo
More testimonials

news from the business location Austria

OMV and Kommunalkredit invest in the production of green hydrogen

The Austrian oil and gas company OMV and Kommunalkredit Austria AG (Kommunalkredit) have announced a joint investment in the construction of Austria’s largest electrolysis plant to be located in the OMV Schwechat Refinery.

Evotec SE

Evotec is an active substance research company which rapidly presses ahead with innovative product approaches on the basis of development partnerships with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists.

More news All blog posts